Mita Kuchimanchi, M.S

Director, Clinical Pharmacology Modeling and Simulation
GSK, Waltham, MA, USA

Poster(s):

• (T-072) Exposure–Response Relationship of Dostarlimab With Chemotherapy in Primary Advanced/Recurrent Endometrial Cancer: Results From Interim Analysis Two of Part 1 of ENGOT-EN6-NSGO/GOG-3031/RUBY Trial
  Tuesday, November 12, 2024

  7:00 AM – 5:00 PM MST